National Advisory Committee on Immunization (NACI)
About NACI
NACI is a national committee of recognized experts in the fields of pediatrics, infectious diseases, immunology, medical microbiology, internal medicine and public health. The Committee reports to the Chief Public Health Officer of Canada, and works with departmental staff of the Centre for Infectious Disease Prevention and Control (CIDPC) of the Public Health Agency of Canada to provide ongoing and timely medical, scientific and public health advice.
NACI makes recommendations for the use of vaccines currently or newly approved for use in humans in Canada, including the identification of groups at risk for vaccine-preventable disease for whom vaccine programs should be targeted. All NACI recommendations on vaccine use in Canada are published every four years in the Canadian Immunization Guide. Additional statements and updates are published in the Canada Communicable Disease Report (CCDR). NACI also advises on the need for national vaccination strategies and makes recommendations for vaccine development research.
Contact us
NACI@phac-aspc.gc.ca
Meetings
October 10-11, 2007, Ottawa, Ontario
February 6-7, 2008, Ottawa, Ontario
June 4-5, 2008, Ottawa, Ontario
October 15-16, 2008, Ottawa, Ontario
Past Meetings:
June 6-7, 2007, Ottawa, Ontario
February 7-8, 2007, Ottawa, Ontario
October 4-5, 2006 Ottawa, Ontario
May 31-June 1 2006 Vancouver, British Columbia
February 7-9, 2006 Ottawa, Ontario
Recent Statements (in order by date)
2007
2006
2005
NACI Recommendations, Statements and Updates (A-Z Index)
Bacille Calmette Guérin (BCG)
Canadian Immunization Guide
For print copies of the Guide, contact:
Publishing and Depository Services
Public Works and Government Services Canada
Ottawa, Ontario K1A 0S5
Telephone: 613-941-5995 or 1-800-635-7943
Fax: 613-954-5779 or 1-800-565-7757
E-mail: publications@pwgsc.gc.ca
Web: http://publications.gc.ca
Cochlear Implant Recipients
Haemophilus Influenzae Type B
Hepatitis
Human Papillomavirus
Immunization Schedules
Influenza
Meningococcal Disease
Pertussis, Tetanus, and Diphtheria
Pneumococcus
Poliomyelitis
Rabies Vaccines
Respiratory Syncytial Virus (RSV)
Typhoid
Smallpox
Thimerosal in Vaccines
Varicella
Literature Reviews
 Membership/Representation
Chairperson
Dr. Joanne Langley
IWK Health Centre and Dalhousie University
Halifax, Nova Scotia
Joanne Langley is on the Faculty of Medicine in the Department of Pediatrics at Dalhousie University. She is Associate Centre Director of the Clinical Trials Research Centre - Infectious Diseases, a consultant in pediatric infectious diseases at the IWK Health Centre and medical director of Infection Control Services. She obtained a BA at Queen's University at Kingston and graduated from Dalhousie Medical School. Her pediatric training was done at the IWK Children's Hospital and the Hospital for Sick Children, Toronto. She completed a Masters of Science in Clinical Epidemiology (Design, Measurement and Evaluation) at McMaster University and postgraduate training in pediatric infectious diseases at the University of Toronto and the Hospital for Sick Children. Dr. Langley's research interests include various aspects of pediatric infectious diseases with a focus on respiratory infections, vaccine preventable diseases and infection control. She currently serves on the National Advisory Committee on Immunization (NACI), the Canadian Pediatric Infectious Disease Society Infectious Diseases and Immunization Committee and the Canadian Task Force on Preventive Health Care.
Vice-Chair
Dr. Bryna Warshawsky
Middlesex-London Health Unit
London, Ontario
Bryna Warshawsky is the Associate Medical Officer of Health and Director, Communicable Disease and Sexual Health Services for the Middlesex-London Health Unit. She graduated from McGill University in Medicine in 1986. After working as a family practitioner for three years, she returned to the University of Toronto and obtained a Master's of Health Science Degree in Epidemiology and Biostatistics, and a fellowship from the Royal College of Physicians and Surgeons in Community Medicine. She joined the Middlesex-London Health Unit in September 1994 where her main areas of responsibilities are the prevention and control of communicable diseases and development of sexual health programming. Her areas of interest include vaccine preventable diseases and outbreak management. She is cross-appointed in both the Departments of Epidemiology and Biostatistics, and Family Medicine at the University of Western Ontario.
MEMBERS
Dr. Simon Dobson
Vaccine Evaluation Centre
Vancouver, British Columbia
Simon Dobson is a Clinical Associate Professor at the University of British Columbia and an attending physician in Pediatric Infectious Diseases at BC's Children's Hospital, Vancouver. He trained in Pediatrics in the United Kingdom and in Pediatric Infectious Diseases at Baylor College of Medicine, Houston. His current research interests are clinical vaccine trials, especially in the pre-teen and adolescent age group, and vaccine adverse events. He works at the Vaccine Evaluation Center, BC's Children's Hospital.
Dr. Bernard Duval
Institut national de santé publique du Québec
Quebec, Quebec
After graduating from Laval University Medical School in 1972, Bernard Duval worked in Africa until 1977. He then completed a Master of Public Health degree in Harvard and became Fellow of the Royal College of Physicians and Surgeons of Canada (Community medicine) in 1980. He was head of the public health services for Northern Quebec Inuit communities before going back to Senegal as a technical advisor for the United Nations. Since 1986, he has been working in Quebec City in control and prevention of communicable diseases. In recent years, his main research activities focused on Hepatitis A and B vaccines. He heads the Groupe scientifique en immunisation of the National Public Health Institute of Québec and is a senior researcher at the Public Health Research Unit, CHUL Research Center, Laval University. He is the executive secretary of the Quebec Advisory Committee on Immunization and a member of the steering committee of the Canadian Association for Immunization Research and Evaluation (CAIRE). He is affiliated with the Social and Preventive Medicine Department of Laval University Medical School.
Ms. Anita Hanrahan
Capital Health
Edmonton, Alberta
Anita Hanrahan is a public health nurse and Director of Communicable Disease Control in the Capital Health Region of Alberta, an integrated health region providing services to approximately one million persons. She completed her Master of Nursing degree from the University of Alberta and is currently an Associate Faculty Member. Under the direction of the Medical Officer of Health, she is responsible for setting the strategic direction of, and standards for, the immunization program in the region, as well as assessing the immunization coverage rates achieved. In addition, she is responsible for the Sexually Transmitted Disease Centre, the Tuberculosis Clinic, Travellers Health Services and the Immunization Business Unit, Regional Infection Control, and the Communicable Disease Nurse Specialists. Anita is also a Facilitator for Health Canada’s Skills Enhancement for Health Surveillance initiative.
Dr. Jim Kellner
University of Calgary
Calgary, Alberta
Jim Kellner is a Professor in the Departments of Pediatrics, Microbiology and Infectious Diseases, and Community Health Sciences at the University of Calgary. He is Head of the Division of Pediatric Infectious Diseases and the Chair of the Alberta Advisory Committee on Communicable Diseases Control. After graduating from the University of Calgary medical school in 1984 he trained in pediatrics and emergency medicine in Calgary and Toronto and practiced emergency pediatrics in both cities for several years.
Dr. Kellner trained in infectious diseases and clinical epidemiology in Toronto and has been in practice with the Division of Infectious Diseases at the Alberta Children's Hospital in Calgary since 1996. His main research interests include the epidemiology of pneumococcal infections, antibiotic resistance in community-acquired infections and antibiotic utilization.
Dr. Kevin B. Laupland
University of Calgary
Calgary, Alberta
Kevin Laupland is an Assistant Professor of Medicine, Critical Care Medicine, Community Health Sciences, and Pathology and Laboratory Medicine at the University of Calgary and is Deputy Director, Centre for Anti-microbial Resistance. He graduated from the University of Toronto in 1996 and completed residencies in Internal Medicine, Infectious Diseases, and Critical Care Medicine and graduate studies in epidemiology at the University of Calgary. His research interests include the population-based epidemiology of severe infections and those due to anti-microbial resistant pathogens.
Dr. Allison McGeer
Mount Sinai/Toronto Medical Laboratories
Toronto, Ontario
Allison McGeer received her BSc and MSc in Biochemistry from the University of
Toronto, before entering medical school. She trained in Internal Medicine
and Infectious Diseases at the University of Toronto, and completed a
fellowship in hospital epidemiology at Yale-New Haven Hospital. She is now
a Microbiologist and the Director of Infection Control at the Mount Sinai Hospital, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto, with cross appointments in Medicine and Public Health Sciences. Her research interests include antimicrobial resistance, infection prevention in hospitals and nursing homes, and adult vaccination.
Dr. Shelly McNeil
QEII Health Sciences Centre
Halifax, Nova Scotia
Shelly McNeil is currently an Assistant Professor of Medicine and Pediatrics and an Infectious Diseases Consultant at the QEII Health Sciences Centre in Halifax, Nova Scotia, Canada. Dr. McNeil completed her medical education at Dalhousie University followed by a three-year residency in Internal Medicine at Dalhousie and a three-year fellowship in Infectious Diseases at the University of Michigan in Ann Arbor.
Dr. McNeil returned to Dalhouise as an Assistant Professor of Medicine in 2000 and is currently cross-appointed with the Department of Pediatrics. Dr. McNeil is a Clinical Investigator at the Clinical Trials Research Center and the Canadian Centre for Vaccinology, Halifax where her research focuses on the evaluation of vaccine-preventable diseases in the elderly and in pregnant women and early-phase clinical trials of new vaccines targeted at adult populations. Dr. McNeil has recently been awarded the Dalhousie University Faculty of Medicine Clinical Research Scholar Award for the period 2005-2010.
Dr. Marie-Noël Primeau
Université de Montréal
Montreal, Quebec
Marie-Noël Primeau is an Associate Professor of Pediatrics at the University of Montreal and an attending physician in allergy and clinical immunology at Sainte-Justine Hospital, Montreal. She graduated from Sherbrooke University in 1994. She trained in pediatrics at Sherbrooke University and in pediatric allergy and immunology at McGill University. She did a clinical research fellowship at the Johns Hopkins Asthma and Allergy Center from 1999 to 2001. Her research interests include allergic reactions to vaccines and medications.
Dr. Blair Seifert
Health Science Centre
Winnipeg, Manitoba
Blair Seifert is a Clinical Pharmacist at the Children's Hospital, Health Sciences Centre in Winnipeg and is cross appointed as Assistant Professor in the Department of Pediatrics and Child Health at the Faculty of Medicine at the University of Manitoba. He is a graduate of the University of Saskatchewan College of Pharmacy, and received his Doctor of Pharmacy degree with a specialty in Pediatric Clinical Pharmacy in 1981.
Dr. Seifert is involved with several Provincial, National and International pharmacy and medical organizations. He has participated in National and International committees and forums related to medication use in children and expectant parents as well as participating in the planning and delivery of continuing, professional development programs for pharmacists, physicians, and nurses, and many education programs for families. The use of vaccines and other immunizing agents to prevent disease is an integral part of his practice.
Dr. Danuta Skowronski
BC Centre for Disease Control
Vancouver, BC
Danuta Skowronski is a physician epidemiologist at the BC Centre for Disease Control responsible for surveillance, policy, program planning and research activities related to respiratory-borne infections. She has been with the BCCDC for 7 years. Prior to this, Dr. Skowronski was a Medical Health Officer in the Lower Mainland of BC for five years. She is a Medical Doctor who subsequently completed a Master's in Epidemiology and Fellowship training in Community Medicine/Public Health.
Dr. Skowronski was responsible for human health recommendations during outbreaks of avian influenza among poultry in British Columbia in 2004 and was also instrumental in the public health response to SARS in BC in 2003.
Dr. Ben Tan
Royal University Hospital
Saskatoon, Saskatchewan
Ben Tan received his medical degree from the University of Toronto in 1984, his certification in paediatrics in 1989 and his certification in infectious diseases in 1991, both from the Royal College of Physicians and Surgeons of Canada. His paediatric residency and his infectious diseases fellowship training were with the Children's Hospital of Eastern Ontario, University of Ottawa. He was field epidemiologist with the Immunization Division of the Laboratory Centre for Disease Control, Health Canada in 1991-92, and has been a paediatric infectious diseases consultant with the Royal University Hospital, Saskatoon since 1992 as well as associate professor since 1995. He also served as program director for the Paediatrics Residency Training Program, University of Saskatchewan from 1998 to 2002 and on the Infectious Diseases and Paediatrics Examination Boards, Royal College of Physicians and Surgeons of Canada from 1996 to 2000 for infectious diseases and since 2002 for paediatrics. He was a member of the Infectious Diseases and Immunization Committee of the Canadian Paediatric Society (CPS) from 1994 to 2000 and Editor-in-chief of the immigrant health guide published by the CPS in 1999. He has been a member of the Immunization Monitoring Program, Active (IMPACT) since 1999.
EXECUTIVE SECRETARY
Dr. Shelley Deeks
Immunization and Respiratory Infections Division
Centre for Infectious Disease Prevention and Control
Public Health Agency of Canada
Ottawa, Ontario
Dr. Shelley Deeks is a senior medical specialist with the Immunization and Respiratory Infections Division, Public Health Agency of Canada and is the Executive Secretary of the National Advisory Committee on Immunization (NACI). She holds a fellowship of the Royal College of Physicians and Surgeons in Community Medicine and completed the Canadian Field Epidemiology Program in 1998. She has worked as a medical epidemiologist at both the local and national levels in Canada and was part of the Health Canada response team on Severe Acute Respiratory Syndrome (SARS) in 2003. She has chaired both the National Invasive Meningococcal Disease and Invasive Group A Streptococcal Disease working groups and is one of the Canadian Steering Committee members for International Circumpolar Surveillance. Her current areas of focus are vaccine-preventable diseases, surveillance and outbreak management and response.
LIAISON REPRESENTATIVES
Canadian Association for Immunization Research and Evaluation (CAIRE)
Dr. David Scheifele
Vancouver, BC
The Association of Medical Microbiology and Infectious Disease Canada (AMMI)
Dr. Pamela Orr
Winnipeg , Manitoba
Canadian Nursing Coalition for Immunization
Ms. Karen Pielak
Vancouver, BC
Canadian Paediatric Society
Dr. Marina Salvadori
London , Ontario
Canadian Public Health Association
Dr. Patricia Hudson
Montreal, Quebec
Centers for Disease Control and Prevention
Dr. Jean Clare Smith
Atlanta, Georgia, USA
College of Family Physicians of Canada
Dr. Shelley Rechner
Hamilton, Ontario
Committee to Advise on Tropical Medicine & Travel
Dr. James Salzman
Vancouver, B.C.
Community and Hospital Infection Control Association - Canada
Ms. Sandra Callery
Hamilton, Ontario
Council of Chief Medical Officers of Health
Dr. Bryce Larke
Whitehorse, Yukon
Society of Obstetricians and Gynaecologists of Canada
Dr. Deborah Money
Vancouver, BC
EX-OFFICIO REPRESENTATIVES
Canadian Forces Health Services Group Headquarters
Major Paul C. Laforce
Communicable Disease Control Program
Ottawa, Ontario
First Nations and Inuit Health Branch
Dr. RoseMarie Ramsingh
Ottawa, Ontario
Health Products and Food Branch
Dr. Harold Rode
Biologics and Genetic Therapies Directorate
Health Canada
Ottawa, Ontario
Immunization and Respiratory Infections Division (IRID)
Dr. Barbara Law
Public Health Agency of Canada
Ottawa, Ontario
Immunization and Respiratory Infections Division (IRID) Programs
Ms. Manahz FarhangMehr
Public Health Agency of Canada
Ottawa, Ontario
Travel Medicine Program
Ms. Raymonde Hickey
Public Health Agency of Canada
Ottawa, Ontario
ADMINISTRATION
Administrative Secretary
Ms. Jennifer Rendall
Immunization and Respiratory Infections Division
Centre for Infectious Disease Prevention and Control
Public Health Agency of Canada
Ottawa, Ontario
|
